Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Prepaid Assets (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Prepaid Assets for 6 consecutive years, with $17.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 2.53% to $17.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.8 million, a 2.53% increase, with the full-year FY2025 number at $17.8 million, up 2.53% from a year prior.
  • Prepaid Assets was $17.8 million for Q4 2025 at Relay Therapeutics, up from $3.7 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $17.8 million in Q4 2025 to a low of $3.3 million in Q4 2022.
  • A 5-year average of $10.3 million and a median of $9.6 million in 2021 define the central range for Prepaid Assets.
  • Biggest YoY gain for Prepaid Assets was 412.49% in 2023; the steepest drop was 73.4% in 2023.
  • Relay Therapeutics' Prepaid Assets stood at $11.5 million in 2021, then tumbled by 71.57% to $3.3 million in 2022, then surged by 412.49% to $16.7 million in 2023, then increased by 3.87% to $17.3 million in 2024, then rose by 2.53% to $17.8 million in 2025.
  • Per Business Quant, the three most recent readings for RLAY's Prepaid Assets are $17.8 million (Q4 2025), $3.7 million (Q3 2025), and $16.0 million (Q2 2025).